CIP
HCAT icon

Cornerstone Investment Partners’s Health Catalyst HCAT Stock Holding History

Cornerstone Investment Partners’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,081
Closed -$98.3K – 265
2024
Q3 		$98.3K Buy
12,081
+387
+3% +$2.8K ﹤0.01% 224
2024
Q2 		$74.7K Sell
11,694
-945
-7% -$6.07K ﹤0.01% 227
2024
Q1 		$95.2K Hold
12,639
– – ﹤0.01% 232
2023
Q4 		$117K Hold
12,639
– – 0.01% 225
2023
Q3 		$128K Sell
12,639
-913
-7% -$10.9K 0.01% 187
2023
Q2 		$169K Buy
+13,552
New +$161K 0.01% 177
2021
Q2 		– Sell
-5,150
Closed -$241K – 304
2021
Q1 		$241K Hold
5,150
– – 0.01% 192
2020
Q4 		$224K Buy
+5,150
New +$190K 0.01% 145

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Cornerstone Investment Partners's HCAT Position: Q4 2024 in Review

Cornerstone Investment Partners sold out of Health Catalyst (HCAT) in Q4 2024, closing a stake of 12,081 shares — an estimated $98.3K sold.

Cornerstone Investment Partners first reported a position in HCAT in Q4 2020 and held it in 8 quarters. The position peaked at $241K in Q1 2021. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2024.

  • Cornerstone Investment Partners reported no remaining Health Catalyst position as of Q4 2024 after selling out during the quarter.
  • Cornerstone Investment Partners sold 12,081 Health Catalyst shares in Q4 2024, an estimated $98.3K.
  • Cornerstone Investment Partners first reported a position in Health Catalyst in Q4 2020 and held it in 8 quarters.
  • Cornerstone Investment Partners's Health Catalyst position peaked at $241K in Q1 2021.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2024.

Based on Cornerstone Investment Partners's 13F filing for Q4 2024, filed 6 Feb 2025.